Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC

Autor: Gulikers, Judith L., Veerman, G.D. Marijn, Jebbink, Merel, Kruithof, Paul D., Steendam, Christi M.J., Boosman, René J., Mathijssen, Ron H.J., Tjan-Heijnen, Vivianne C.G., Driessen, Johanna H.M., Dursun, Safiye, Smit, Egbert F., Dingemans, Anne-Marie C., van Geel, Robin M.J.M., Croes, Sander, Hendriks, Lizza E.L.
Zdroj: In JTO Clinical and Research Reports April 2024 5(4)
Databáze: ScienceDirect